Short Interest in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Increases By 57.2%

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 50,000 shares, an increase of 57.2% from the July 31st total of 31,800 shares. Based on an average daily trading volume, of 140,500 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.3% of the shares of the company are short sold.

Institutional Investors Weigh In On Inspira Technologies Oxy B.H.N.

A hedge fund recently bought a new stake in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC acquired a new position in shares of Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.19% of Inspira Technologies Oxy B.H.N. at the end of the most recent reporting period. Institutional investors own 12.72% of the company’s stock.

Inspira Technologies Oxy B.H.N. Stock Performance

Shares of IINN traded down $0.02 during trading hours on Thursday, reaching $1.10. The company had a trading volume of 8,090 shares, compared to its average volume of 542,015. The firm has a 50 day simple moving average of $1.17 and a 200-day simple moving average of $1.62. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.61 and a current ratio of 2.61. Inspira Technologies Oxy B.H.N. has a 12-month low of $0.76 and a 12-month high of $2.49.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.